Quang Dai Le

Quang Dai Le

Auto-generated profile, based on publicly available information

Quang Dai Le

Faculty of Medicine, College of Health Sciences, Nam Can Tho University, Can Tho, Vietnam

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2025 in Critical Care
Verified
Journal Article
Open access
PDF file
TNThanh Luan Nguyen
Thanh Luan Nguyen
PDPhieu Van Duong
Phieu Van Duong
HDHoang Ngoc Thao Duong
Hoang Ngoc Thao Duong
PPPhuc Tuong Pham
Phuc Tuong Pham
VHVan Hoang Nam Ho
Van Hoang Nam Ho
CTCong Dang Tran
Cong Dang Tran

6 January 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
TNThanh Luan Nguyen
Thanh Luan Nguyen
QLQuang Dai Le
Quang Dai Le
TDTrang Nguyen Hoai Dinh
Trang Nguyen Hoai Dinh
VHVan Hoang Nam Ho
Van Hoang Nam Ho
CTCong Dang Tran
Cong Dang Tran
TBTuyet Phuong Bui
Tuyet Phuong Bui

11 May 2026 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
TNThanh Luan Nguyen
Thanh Luan Nguyen
HDHoang Ngoc Thao Duong
Hoang Ngoc Thao Duong
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
QLQuang Dai Le
Quang Dai Le
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh
PDPhieu Van Duong
Phieu Van Duong
Background: Disturbances in magnesium homeostasis and magnesium supplementation are common in critical illness; however, the association between early intravenous magnesium sulfate administration and clinical outcomes in critically ill patients with pneumonia remains unclear. Methods: This retrospective observational cohort study used data from the Medical Information Mart for Intensive Care IV (version 3.1) database and included critically ill patients admitted to the intensive care unit (ICU) with pneumonia. Patients were classified according to early exposure to intravenous magnesium sulfate, defined as administration from 6 h before to 24 h after ICU admission, or no exposure during this period. The primary outcome was 30-day all-cause mortality, with secondary outcomes including 60-day and 90-day mortality. Associations were evaluated using multivariable Cox proportional hazards models, with prespecified subgroup, interaction, and sensitivity analyses, including propensity score matching. Results: Among 9203 eligible patients, 2975 (32.3%) received early intravenous magnesium sulfate. Magnesium sulfate administration was associated with lower 30-day mortality after multivariable adjustment (adjusted hazard ratio [aHR] 0.84; 95% confidence interval [CI] 0.76-0.94; p = .002). Similar associations were observed for 60-day mortality (aHR 0.86; 95% CI 0.78-0.95; p = .002) and 90-day mortality (aHR 0.87; 95% CI 0.80-0.96; p = .004). Subgroup analysis identified a significant interaction for sepsis status (p for interaction = .007). In a propensity score–matched cohort, magnesium sulfate administration remained associated with lower 30-day mortality (aHR 0.85; 95% CI 0.74-0.96; p = .012). Conclusions: In critically ill patients with pneumonia, early intravenous magnesium sulfate administration was associated with lower mortality. These findings are hypothesis-generating and suggest the need for prospective studies to clarify causality and define optimal dosing and duration of magnesium supplementation in this population.

12 June 2026 in Medicine
Verified
Journal Article
Open access
NTNhuan Thu To
Nhuan Thu To
TBTuyet Phuong Bui
Tuyet Phuong Bui
VHVan Hoang Nam Ho
Van Hoang Nam Ho
QLQuang Dai Le
Quang Dai Le
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
TNThanh Luan Nguyen
Thanh Luan Nguyen
The prognostic value of the modified Nutrition Risk in the Critically Ill (mNUTRIC) score in patients with severe and critical Coronavirus disease 2019 (COVID-19) remains insufficiently defined. This study aimed to assess the predictive performance of the mNUTRIC score for in-hospital mortality in patients with severe and critical COVID-19 admitted to the intensive care unit. We conducted a retrospective cohort study including 355 critically ill patients with severe and critical COVID-19 admitted to a university-affiliated hospital in Vietnam. The mNUTRIC score was calculated using the first available clinical and laboratory values recorded within the first 24 hours of intensive care unit admission. The primary outcome was in-hospital mortality. Associations between the mNUTRIC score and mortality were assessed using multivariable logistic regression. Predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC). Overall in-hospital mortality was 36.1%. High nutritional risk, defined as an mNUTRIC score ≥5, was identified in 29.6% of patients. In multivariable analysis, the mNUTRIC score remained independently associated with in-hospital mortality (adjusted odds ratio 1.58, 95% confidence interval 1.24–2.02; P < .001). The mNUTRIC score demonstrated moderate discriminative performance for predicting in-hospital mortality, with an AUC of 0.750 (95% confidence interval 0.698–0.803; P < .001). At the optimal cutoff value of ≥4.5, the sensitivity and specificity for predicting in-hospital mortality were 54.7% and 84.6%, respectively. In critically ill patients with severe and critical COVID-19, the mNUTRIC score was associated with in-hospital mortality and demonstrated moderate prognostic performance. Given the retrospective design, these findings should be interpreted with caution and warrant further prospective validation.